Mechanistically, serum levels of SCFAs were higher in NSCLC patients who responded to ICI therapy than in non-responders, and positively correlated with PD-1 expression on peripheral CD8+ T cells and Vγ9Vδ2 (Vδ2+) T cells. Here, PDCD1 is linked to non-small cell lung carcinoma.